Feb 09, 2024 / 11:30AM GMT
Operator
Ladies and gentlemen, good day. Welcome to the Neuland Laboratories Limited Q3 and nine-month FY24 earnings conference call. (Operator Instructions) Note that this conference is being recorded.
I now hand the conference over to o Mr. Ravi Udeshi from Ernst & Young. Thank you, and over to you, sir.
Ravi Udeshi - Ernst & Young - Analyst
Thank you, Muskan. Good evening, friends. We welcome you to the Q3 and nine months FY24 earnings conference call of Neuland Laboratories Limited. To take us through the results and to answer your questions, we have with us the top management from Neuland Laboratories represented by Mr. Sucheth Davuluri, Vice Chairman and CEO; Mr. Saharsh Davuluri, Vice Chairman and Managing Director; Mr. Abhijit Majumdar, CFO; and Mr. Sajeev Emmanuel Medikonda, Head, Corporate Planning and Strategy.
We will start the call with a brief overview of the financials by Mr. Abhijit Majumdar. And then, Saharsh will give you broad highlights of the business trends and what he is observing in the market. And post that, we will
Q3 2024 Neuland Laboratories Ltd Earnings Call Transcript
Feb 09, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers